288 related articles for article (PubMed ID: 1327388)
1. Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.
Gryglewski RJ; Zembowicz A; Salvemini D; Taylor GW; Vane JR
Br J Pharmacol; 1992 Aug; 106(4):838-45. PubMed ID: 1327388
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nitrovasodilators by pyocyanin and methylene blue is dissociated from nitric oxide formation.
Bozinovski J; Brien JF; Marks GS; Nakatsu K
Can J Physiol Pharmacol; 1994 Jul; 72(7):746-52. PubMed ID: 7828082
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the action of nitric oxide prodrugs by pyocyanin: mechanistic studies.
Hussain AS; Bozinovski J; Maurice DH; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 1997 May; 75(5):398-406. PubMed ID: 9250373
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
Salvemini D; Currie MG; Mollace V
J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
[TBL] [Abstract][Full Text] [Related]
5. Vasorelaxant and platelet-suppressant potencies of four NO-donors.
Zembowicz A; Dudek RD; Radziszewski W; Swierkosz TA; Trybulec M; Gryglewski RJ
Pol J Pharmacol Pharm; 1990; 42(3):275-81. PubMed ID: 2124687
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
Marks GS; McLaughlin BE; Jimmo SL; Poklewska-Koziell M; Brien JF; Nakatsu K
Drug Metab Dispos; 1995 Nov; 23(11):1248-52. PubMed ID: 8591726
[TBL] [Abstract][Full Text] [Related]
7. Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators.
Zhou HL; Torphy TJ
J Pharmacol Exp Ther; 1991 Sep; 258(3):972-8. PubMed ID: 1679854
[TBL] [Abstract][Full Text] [Related]
8. S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators.
Henry PJ; Drummer OH; Horowitz JD
Br J Pharmacol; 1989 Nov; 98(3):757-66. PubMed ID: 2511992
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of nitrovasodilators and cyclic GMP on ET-1-activated Ca(2+)-permeable nonselective cation channel in rat aortic smooth muscle cells.
Minowa T; Miwa S; Kobayashi S; Enoki T; Zhang XF; Komuro T; Iwamuro Y; Masaki T
Br J Pharmacol; 1997 Apr; 120(8):1536-44. PubMed ID: 9113376
[TBL] [Abstract][Full Text] [Related]
10. Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin.
Gruetter CA; Gruetter DY; Lyon JE; Kadowitz PJ; Ignarro LJ
J Pharmacol Exp Ther; 1981 Oct; 219(1):181-6. PubMed ID: 6270297
[TBL] [Abstract][Full Text] [Related]
11. Nitrovasodilator-induced relaxation and tolerance development in porcine vena cordis magna: dependence on intact endothelium.
Kojda G; Beck JK; Meyer W; Noack E
Br J Pharmacol; 1994 Jun; 112(2):533-40. PubMed ID: 7521258
[TBL] [Abstract][Full Text] [Related]
12. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes.
Schröder H; Ney P; Woditsch I; Schrör K
Eur J Pharmacol; 1990 Jul; 182(2):211-8. PubMed ID: 1697805
[TBL] [Abstract][Full Text] [Related]
13. Myocardial contractile response to nitric oxide and cGMP.
Mohan P; Brutsaert DL; Paulus WJ; Sys SU
Circulation; 1996 Mar; 93(6):1223-9. PubMed ID: 8653845
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide donors as generators and scavengers of superoxide anions.
Robak J; Gryglewski RJ
Pol J Pharmacol; 1993; 45(1):51-8. PubMed ID: 8401759
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of nitrovasodilators and nitric oxide on porcine tracheal and bronchial muscle in vitro.
Stuart-Smith K; Bynoe TC; Lindeman KS; Hirshman CA
J Appl Physiol (1985); 1994 Sep; 77(3):1142-7. PubMed ID: 7836115
[TBL] [Abstract][Full Text] [Related]
17. Effect of carbenoxolone on the biological activity of nitric oxide: relation to gastroprotection.
Dembinska-Kiec A; Pallapies D; Simmet T; Peskar BM; Peskar BA
Br J Pharmacol; 1991 Dec; 104(4):811-6. PubMed ID: 1725764
[TBL] [Abstract][Full Text] [Related]
18. Conversion of glyceryl trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells.
Salvemini D; Pistelli A; Vane J
Br J Pharmacol; 1993 Jan; 108(1):162-9. PubMed ID: 8381319
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices.
Southam E; Garthwaite J
Neurosci Lett; 1991 Sep; 130(1):107-11. PubMed ID: 1660968
[TBL] [Abstract][Full Text] [Related]
20. Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery.
Plane F; Wiley KE; Jeremy JY; Cohen RA; Garland CJ
Br J Pharmacol; 1998 Apr; 123(7):1351-8. PubMed ID: 9579730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
